Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Outpatient High Dose Methotrexate in Osteosarcoma
NCT01176981Phase 3Completed
- Sponsor
- SickKids
- Start
- Oct 2010
- Primary completion
- Oct 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of methotrexate in osteosarcoma (OS), sponsored by SickKids. Primary endpoint: The Number of Outpatient High Dose Methotrexate Courses Which Result in an Inpatient Hospital Admission at 9 months. Started Oct 2010; status: completed.
02
Drugs
methotrexate
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT01176981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01176981.